Daily ‘polypill’ cuts risk of heart disease by up to 40%
A polypill combining four cheap cardiovascular medicines substantially reduces the risk of serious heart disease, the concept’s first large clinical trial has shown. THE FINANCIAL TIMES
A polypill combining four cheap cardiovascular medicines substantially reduces the risk of serious heart disease, the concept’s first large clinical trial has shown. THE FINANCIAL TIMES